UTHR logo

United Therapeutics (UTHR) EBIT

annual EBIT:

$1.58B+$248.30M(+18.62%)
December 31, 2024

Summary

  • As of today (May 29, 2025), UTHR annual earnings before interest & taxes is $1.58 billion, with the most recent change of +$248.30 million (+18.62%) on December 31, 2024.
  • During the last 3 years, UTHR annual EBIT has risen by +$969.40 million (+158.27%).
  • UTHR annual EBIT is now at all-time high.

Performance

UTHR EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

quarterly EBIT:

$429.60M+$25.20M(+6.23%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR quarterly earnings before interest & taxes is $429.60 million, with the most recent change of +$25.20 million (+6.23%) on March 31, 2025.
  • Over the past year, UTHR quarterly EBIT has increased by +$17.70 million (+4.30%).
  • UTHR quarterly EBIT is now -41.76% below its all-time high of $737.60 million, reached on September 30, 2015.

Performance

UTHR quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

TTM EBIT:

$1.60B+$17.70M(+1.12%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR TTM earnings before interest & taxes is $1.60 billion, with the most recent change of +$17.70 million (+1.12%) on March 31, 2025.
  • Over the past year, UTHR TTM EBIT has increased by +$159.80 million (+11.10%).
  • UTHR TTM EBIT is now at all-time high.

Performance

UTHR TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

UTHR EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+18.6%+4.3%+11.1%
3 y3 years+158.3%+37.1%+80.0%
5 y5 years+1409.5%+138.9%+128.7%

UTHR EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+158.3%at high+174.0%at high+94.0%
5 y5-yearat high+1409.5%at high+1058.0%at high+207.8%
alltimeall timeat high+1409.5%-41.8%+167.1%at high+993.1%

UTHR EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$429.60M(+6.2%)
$1.60B(+1.1%)
Dec 2024
$1.58B(+18.6%)
$404.40M(+1.4%)
$1.58B(+6.3%)
Sep 2024
-
$398.70M(+8.7%)
$1.49B(+2.1%)
Jun 2024
-
$366.90M(-10.9%)
$1.46B(+1.2%)
Mar 2024
-
$411.90M(+32.7%)
$1.44B(+8.0%)
Dec 2023
$1.33B(+35.7%)
$310.50M(-15.5%)
$1.33B(+9.8%)
Sep 2023
-
$367.40M(+5.0%)
$1.21B(+3.9%)
Jun 2023
-
$350.00M(+14.5%)
$1.17B(+19.8%)
Mar 2023
-
$305.70M(+60.0%)
$975.30M(-0.8%)
Dec 2022
$983.00M(+60.5%)
$191.10M(-40.6%)
$983.00M(+4.9%)
Sep 2022
-
$321.70M(+105.2%)
$937.10M(+13.7%)
Jun 2022
-
$156.80M(-50.0%)
$824.40M(-7.2%)
Mar 2022
-
$313.40M(+115.8%)
$888.80M(+45.1%)
Dec 2021
$612.50M(-7.5%)
$145.20M(-30.5%)
$612.50M(+4.4%)
Sep 2021
-
$209.00M(-5.5%)
$586.50M(-2.5%)
Jun 2021
-
$221.20M(+496.2%)
$601.40M(+15.7%)
Mar 2021
-
$37.10M(-68.9%)
$519.70M(-21.5%)
Dec 2020
$662.40M(-648.3%)
$119.20M(-46.8%)
$662.40M(+6.6%)
Sep 2020
-
$223.90M(+60.5%)
$621.50M(+7.9%)
Jun 2020
-
$139.50M(-22.4%)
$576.20M(-17.6%)
Mar 2020
-
$179.80M(+129.6%)
$699.30M(-678.9%)
Dec 2019
-$120.80M(-115.6%)
$78.30M(-56.2%)
-$120.80M(+17.4%)
Sep 2019
-
$178.60M(-32.0%)
-$102.90M(-25.1%)
Jun 2019
-
$262.60M(-141.0%)
-$137.30M(-23.3%)
Mar 2019
-
-$640.30M(-765.6%)
-$179.10M(-123.2%)
Dec 2018
$772.80M(-0.7%)
$96.20M(-33.3%)
$772.80M(-5.9%)
Sep 2018
-
$144.20M(-34.7%)
$821.10M(-18.0%)
Jun 2018
-
$220.80M(-29.1%)
$1.00B(+21.2%)
Mar 2018
-
$311.60M(+115.6%)
$825.70M(+6.1%)
Dec 2017
$778.50M(-26.8%)
$144.50M(-55.4%)
$778.50M(-3.6%)
Sep 2017
-
$324.00M(+610.5%)
$807.70M(+11.7%)
Jun 2017
-
$45.60M(-82.8%)
$723.30M(-25.0%)
Mar 2017
-
$264.40M(+52.2%)
$964.00M(-9.4%)
Dec 2016
$1.06B(+1.4%)
$173.70M(-27.5%)
$1.06B(+1.6%)
Sep 2016
-
$239.60M(-16.3%)
$1.05B(-32.2%)
Jun 2016
-
$286.30M(-21.5%)
$1.54B(+8.2%)
Mar 2016
-
$364.50M(+132.9%)
$1.43B(+36.1%)
Dec 2015
$1.05B(+93.3%)
$156.50M(-78.8%)
$1.05B(-2.0%)
Sep 2015
-
$737.60M(+334.6%)
$1.07B(+254.4%)
Jun 2015
-
$169.70M(-1254.4%)
$302.19M(-2.6%)
Mar 2015
-
-$14.70M(-108.2%)
$310.27M(-42.8%)
Dec 2014
$542.80M(+82.8%)
$178.32M(-672.9%)
$542.80M(+60.9%)
Sep 2014
-
-$31.12M(-117.5%)
$337.41M(-28.9%)
Jun 2014
-
$177.78M(-18.4%)
$474.26M(+13.0%)
Mar 2014
-
$217.83M(-904.7%)
$419.52M(+41.3%)
Dec 2013
$296.96M(-35.1%)
-$27.07M(-125.6%)
$296.96M(-34.5%)
Sep 2013
-
$105.72M(-14.1%)
$453.47M(-1.6%)
Jun 2013
-
$123.04M(+29.1%)
$460.63M(+3.6%)
Mar 2013
-
$95.27M(-26.4%)
$444.76M(-2.7%)
Dec 2012
$457.31M(+42.7%)
$129.44M(+14.7%)
$457.31M(+16.4%)
Sep 2012
-
$112.88M(+5.3%)
$392.97M(+2.4%)
Jun 2012
-
$107.17M(-0.6%)
$383.76M(-2.0%)
Mar 2012
-
$107.82M(+65.6%)
$391.64M(+21.9%)
DateAnnualQuarterlyTTM
Dec 2011
$320.48M(+83.3%)
$65.10M(-37.2%)
$321.29M(+17.9%)
Sep 2011
-
$103.67M(-9.9%)
$272.44M(+17.5%)
Jun 2011
-
$115.05M(+207.0%)
$231.92M(+29.6%)
Mar 2011
-
$37.47M(+130.7%)
$178.94M(+2.3%)
Dec 2010
$174.86M(+452.6%)
$16.25M(-74.3%)
$174.84M(+11.0%)
Sep 2010
-
$63.15M(+1.7%)
$157.52M(+47.6%)
Jun 2010
-
$62.07M(+86.0%)
$106.74M(+151.9%)
Mar 2010
-
$33.37M(-3206.9%)
$42.38M(+33.9%)
Dec 2009
$31.64M(-143.8%)
-$1.07M(-108.7%)
$31.64M(-131.7%)
Sep 2009
-
$12.38M(-639.3%)
-$99.97M(+8.1%)
Jun 2009
-
-$2.29M(-110.1%)
-$92.47M(+29.9%)
Mar 2009
-
$22.63M(-117.1%)
-$71.18M(-10.0%)
Dec 2008
-$72.28M(-485.3%)
-$132.69M(-767.5%)
-$79.06M(-237.1%)
Sep 2008
-
$19.88M(+4.7%)
$57.68M(+11.0%)
Jun 2008
-
$18.99M(+28.7%)
$51.96M(+26.7%)
Mar 2008
-
$14.75M(+263.4%)
$41.02M(+118.7%)
Dec 2007
$18.76M(-35.3%)
$4.06M(-71.3%)
$18.76M(+2.8%)
Sep 2007
-
$14.16M(+76.0%)
$18.25M(+17.5%)
Jun 2007
-
$8.04M(-207.2%)
$15.52M(-18.3%)
Mar 2007
-
-$7.50M(-311.5%)
$18.99M(-34.5%)
Dec 2006
$28.98M(-32.4%)
$3.55M(-69.0%)
$28.98M(-19.0%)
Sep 2006
-
$11.43M(-0.7%)
$35.79M(-8.0%)
Jun 2006
-
$11.52M(+363.6%)
$38.89M(+0.9%)
Mar 2006
-
$2.48M(-76.0%)
$38.54M(-10.2%)
Dec 2005
$42.89M(+224.7%)
$10.36M(-28.8%)
$42.89M(+10.4%)
Sep 2005
-
$14.54M(+30.2%)
$38.85M(+29.4%)
Jun 2005
-
$11.16M(+63.2%)
$30.01M(+33.9%)
Mar 2005
-
$6.84M(+8.3%)
$22.42M(+69.7%)
Dec 2004
$13.21M(-214.6%)
$6.31M(+10.8%)
$13.21M(+291.6%)
Sep 2004
-
$5.70M(+59.6%)
$3.37M(-182.9%)
Jun 2004
-
$3.57M(-250.5%)
-$4.07M(-61.1%)
Mar 2004
-
-$2.37M(-32.6%)
-$10.47M(-9.2%)
Dec 2003
-$11.53M(-36.0%)
-$3.52M(+102.1%)
-$11.53M(+3.7%)
Sep 2003
-
-$1.74M(-38.4%)
-$11.12M(-30.1%)
Jun 2003
-
-$2.83M(-17.6%)
-$15.91M(+10.0%)
Mar 2003
-
-$3.43M(+10.2%)
-$14.46M(-19.7%)
Dec 2002
-$18.00M(-61.6%)
-$3.11M(-52.4%)
-$18.00M(-26.2%)
Sep 2002
-
-$6.54M(+374.0%)
-$24.40M(-18.0%)
Jun 2002
-
-$1.38M(-80.2%)
-$29.76M(-28.0%)
Mar 2002
-
-$6.97M(-26.7%)
-$41.36M(-10.6%)
Dec 2001
-$46.94M(-42.4%)
-$9.51M(-20.0%)
-$46.28M(-31.8%)
Sep 2001
-
-$11.90M(-8.3%)
-$67.83M(+2.2%)
Jun 2001
-
-$12.97M(+9.1%)
-$66.36M(-20.9%)
Mar 2001
-
-$11.89M(-61.7%)
-$83.91M(+3.0%)
Dec 2000
-$81.50M(+130.5%)
-$31.07M(+198.1%)
-$81.50M(+36.1%)
Sep 2000
-
-$10.42M(-65.8%)
-$59.89M(+5.9%)
Jun 2000
-
-$30.52M(+221.6%)
-$56.57M(+75.4%)
Mar 2000
-
-$9.49M(+0.3%)
-$32.25M(-8.0%)
Dec 1999
-$35.36M(+165.0%)
-$9.46M(+33.3%)
-$35.06M(+37.0%)
Sep 1999
-
-$7.10M(+14.5%)
-$25.60M(+38.4%)
Jun 1999
-
-$6.20M(-49.6%)
-$18.50M(+50.4%)
Mar 1999
-
-$12.30M
-$12.30M
Dec 1998
-$13.35M
-
-

FAQ

  • What is United Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for United Therapeutics?
  • What is United Therapeutics annual EBIT year-on-year change?
  • What is United Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for United Therapeutics?
  • What is United Therapeutics quarterly EBIT year-on-year change?
  • What is United Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for United Therapeutics?
  • What is United Therapeutics TTM EBIT year-on-year change?

What is United Therapeutics annual earnings before interest & taxes?

The current annual EBIT of UTHR is $1.58B

What is the all time high annual EBIT for United Therapeutics?

United Therapeutics all-time high annual earnings before interest & taxes is $1.58B

What is United Therapeutics annual EBIT year-on-year change?

Over the past year, UTHR annual earnings before interest & taxes has changed by +$248.30M (+18.62%)

What is United Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of UTHR is $429.60M

What is the all time high quarterly EBIT for United Therapeutics?

United Therapeutics all-time high quarterly earnings before interest & taxes is $737.60M

What is United Therapeutics quarterly EBIT year-on-year change?

Over the past year, UTHR quarterly earnings before interest & taxes has changed by +$17.70M (+4.30%)

What is United Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of UTHR is $1.60B

What is the all time high TTM EBIT for United Therapeutics?

United Therapeutics all-time high TTM earnings before interest & taxes is $1.60B

What is United Therapeutics TTM EBIT year-on-year change?

Over the past year, UTHR TTM earnings before interest & taxes has changed by +$159.80M (+11.10%)
On this page